Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
HUMANIGEN, INC | Director | Stock Option (Right to Buy) | 73.3K | $332K | $4.53 | Jul 27, 2022 | Direct |
Omega Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 25K | Jun 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OMGA | Omega Therapeutics, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
OMGA | Omega Therapeutics, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
OMGA | Omega Therapeutics, Inc. | Aug 31, 2022 | 1 | $0 | 4 | Sep 1, 2022 | Director |
OMGA | Omega Therapeutics, Inc. | Aug 31, 2022 | 0 | $0 | 3 | Sep 1, 2022 | Director |
HGEN | HUMANIGEN, INC | Jul 27, 2022 | 1 | $0 | 4 | Jul 29, 2022 | Director |
HGEN | HUMANIGEN, INC | Dec 31, 2021 | 1 | $14.5K | 4 | Jan 4, 2022 | Director |